Laobaixing Pharmacy Chain schedules Q3 2025 earnings briefing

Laobaixing Pharmacy Chain Co., Ltd. will hold its third-quarter 2025 earnings briefing on Tuesday, December 2, 2025, from 10:00 AM to 11:30 AM. The event will be hosted on the Shanghai Stock Exchange Roadshow Center website, featuring a video live stream and online interaction. This briefing aims to provide investors with an in-depth understanding of the company's Q3 2025 operating results and financial condition, which were disclosed in its Q3 2025 report on October 29, 2025.

Shareholders can submit questions in advance from Tuesday, November 25, 2025, until 4:00 PM on Monday, December 1, 2025, by visiting the "Question Collection" section on the Shanghai Stock Exchange Roadshow Center website or by emailing ir@lbxdrugs.com. The company's board, including chairman and president Mr. Xie Zilong, independent directors, cfo Mr. Chen Lishan, and board secretary Ms. Feng Shinni, will participate and address investor queries during the live session.

Following the briefing, a recording and key content will be accessible on the Shanghai Stock Exchange Roadshow Center website. Investors can also scan a QR code provided in the announcement for a simplified "one-picture" summary of the Q3 2025 report. For any inquiries, investors may contact the company's securities affairs department at 0731-84035189 or via email at ir@lbxdrugs.com.